Kader v. Sarepta Therapeutics, Inc
Kader v. Sarepta Therapeutics, Inc is a federal securities / commodities lawsuit filed on 12/03/2014 in the District Court, D. Massachusetts. The case was terminated on 01/06/2017.
- Court
- District Court, D. Massachusetts (D. Mass.)
Official Court Website → - Assigned judge
- Allison D. Burroughs · 1,236 cases in index
- Docket number
- 1:14-cv-14318
- Cause
- 15:78m(a) Securities Exchange Act
15 U.S.C. § 78m - Nature of suit
- 850 Securities/Commodities
Alleged violations of federal securities or commodities laws. - Jurisdiction
- Federal Question
- Jury demand
- Plaintiff
- Date filed
- 12/03/2014
- Date terminated
- 01/06/2017
1,814 Securities / Commodities cases in this court are indexed here.
Parties
- plaintiff · Kader · 11 cases
- defendant · Sarepta Therapeutics, Inc Pharmaceuticals & Biotechnology · 13 cases
Part of a Larger Litigation Pattern
This is one of 14 Securities / Commodities cases in our index naming Sarepta Therapeutics, Inc — a possible mass-tort or coordinated-litigation cluster.
About Securities / Commodities Lawsuits
Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
Frequently Asked Questions
What is Kader v. Sarepta Therapeutics, Inc?
Kader v. Sarepta Therapeutics, Inc is a federal securities / commodities lawsuit filed on 12/03/2014 in the District Court, D. Massachusetts. The case was terminated on 01/06/2017. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What type of case is this?
It is classified as “Securities / Commodities” under the federal nature-of-suit system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What court is the case in?
The case is in the District Court, D. Massachusetts, docket number 1:14-cv-14318.
When was the case filed?
Kader v. Sarepta Therapeutics, Inc was filed on 12/03/2014. It was terminated on 01/06/2017.
What law is the case brought under?
The docket lists the cause as 15 U.S.C. § 78m.
Other Cases Involving These Parties
Related Securities / Commodities Cases
Source: public U.S. federal court record (docket 5172940).